Abstract：Objective To investigate the status of latent tuberculosis infection (LTBI) and tuberculosis preventive treatment (TPT) among HIV/AIDS cases in Wenzhou City, Zhejiang Province, and to analyze the influencing factors of LTBI, so as to provide the evidence for optimizing active tuberculosis screening and early intervention strategies. Methods Study subjects were HIV/AIDS cases who received antiretroviral therapy and CD4+T lymphocyte count testing at designated HIV treatment hospitals from October 2024 to August 2025. The interferon-gamma release assay was used for LTBI screening. Data on HIV/AIDS cases, including gender, age, and other variables, were collected through the Surveillance System of China Information System for Disease Control and Prevention. A multivariable logistic regression model was used to analyze the influencing factors for LTBI among HIV/AIDS cases. Results A total of 3 719 HIV/AIDS cases were included, including 2 983 males (80.21%) and 736 females (19.79%). The study population was predominantly aged 40-<65 years, with 1 948 individuals accounting for 52.38%. LTBI was detected in 399 cases, with a detection rate of 10.73%. Among LTBI cases, 103 received TPT, representing a TPT rate of 25.81%. Multivariable logistic regression analysis showed that HIV/AIDS cases who were male (OR=1.796, 95%CI: 1.326-2.431), aged ≥40 years (40-<65 years, OR=1.895, 95%CI: 1.424-2.523; ≥65 years, OR=2.365, 95%CI: 1.575-3.551), non-Wenzhou household registration (OR=1.462, 95%CI: 1.150-1.857), with education level below junior college (primary school and below, OR=1.578, 95%CI: 1.023-2.394; junior high school, OR=1.725, 95%CI: 1.161-2.562; high school/technical secondary school, OR=1.639, 95%CI: 1.066-2.518), CD4+T lymphocyte count ≥500 cells/μL (OR=2.642, 95%CI: 1.420-4.915), and at the HIV infection stage (OR=1.322, 95%CI: 1.022-1.709) had a higher risk of LTBI. Conclusions The detection rate of LTBI and the TPT rate among LTBI cases are relatively low among HIV/AIDS cases in Wenzhou City. Gender, age, household registration, education level, CD4+T lymphocyte count, and disease stage are influencing factors for LTBI in HIV/AIDS cases.
[1] NIU L,WANG H,LUO G,et al.Advances in understanding immune homeostasis in latent tuberculosis infection[J/OL].WIREs Mech Dis,2024,16(4)[2026-04-19].https://doi.org/10.1002/wsbm.1643. [2] TADEGE M.Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia[J/OL].BMC Res Notes,2018,11(1)[2026-04-19].https://doi.org/10.1186/s13104-018-3863-y. [3] Joint United Nations Programme on HIV/AIDS.In danger:UNAIDS global AIDS update 2022[M].Geneva:Joint United Nations Programme on HIV/AIDS,2022. [4] 高磊,张慧,胡茂桂,等.基于多中心调查数据和空间统计模型的全国结核分枝杆菌杆菌潜伏感染率估算[J].中国防痨杂志,2022,44(1):54-59. [5] World Health Organization.Global tuberculosis report 2025[R].Geneva:WHO,2025. [6] 中华人民共和国国家卫生健康委员会办公厅.关于印发中国结核病预防控制工作技术规范(2020年版)的通知[EB/OL].[2026-04-19].http://tb.chinacdc.cn/ggl/202004/P020200414515703939844.pdf. [7] 罗丹,陈松华,张钰,等.2015—2021年浙江省MTB/HIV双重感染筛查现状及趋势分析[J].结核与肺部疾病杂志,2022,3(6):443-448. [8] 李冰洁,钱克莉,李茜,等.HIV感染者行γ-干扰素释放试验用于筛查潜伏性结核感染的临床价值[J].东南大学学报(医学版),2022,41(4):471-476. [9] 王慧,李锦成,陆兴,等.重组结核杆菌融合蛋白皮肤试验筛查HIV/AIDS病例结核分枝杆菌潜伏感染的效果分析[J].预防医学,2024,36(7):639-643. [10] 李子涵,梁建国,杜江,等.基于酶联免疫吸附法的γ-干扰素释放试验在村医人群的一致性评价[J].中国人兽共患病学报,2025,41(11):1107-1113. [11] 李萌,李杰,孙辉,等.艾滋病患者结核潜伏感染检出率及相关因素分析[J].华南预防医学,2025,51(10):1107-1109. [12] 洪可,张定宇,阮连国.武汉市HIV/AIDS患者潜伏性结核感染筛查及预防效果[J].传染病信息,2021,34(5):422-425. [13] 谢周华,韦柳迎,董文逸,等.HIV/AIDS合并结核分枝杆菌潜伏感染特征及影响因素分析[J].中国热带医学,2022,22(8):739-743. [14] 王慧,卜春虹,陆兴,等.重组结核杆菌融合蛋白皮肤试验筛查HIV/AIDS患者中结核潜伏感染的影响因素研究[J].华南预防医学,2024,50(12):1124-1129. [15] RICKMAN H M,PHIN M D,FEASEY H R A,et al.Sex differences in the risk of Mycobacterium tuberculosis infectio:a systematic review and meta-analysis of population-based immunoreactivity surveys[J/OL].Lancet Public Health,2025,10(7)[2026-04-19].https://doi.org/10.1016/S2468-2667(25)00120-3. [16] 陈瑞麒,张明五,王伟,等.浙江省常山县农村老年人结核分子杆菌潜伏感染情况及影响因素[J].中国防痨杂志,2025,46(4):383-389. [17] 雷蓉蓉,张婷,吴成果,等.南川区居民结核潜伏感染调查[J].预防医学,2022,34(4):371-374. [18] 雷蓉蓉,隆红霞,罗翠红,等.重庆市病原学阳性肺结核患者密切接触者结核分枝杆菌潜伏感染现状及影响因素[J].中国感染控制杂志,2024,23(3):265-270. [19] 曾真,赵丽娜,单志力,等.温州市企业职工结核分枝杆菌潜伏感染调查[J].预防医学,2026,38(4):334-337. [20] AZEVEDO-PEREIRA J M,PIRES D,CALADO M,et al.HIV/MTB co-infection:from the amplification of disease pathogenesis to an “Emerging Syndemic”[J/OL].Microorganisms,2023,11(4)[2026-04-19].https://doi.org/10.3390/microorganisms11040853. [21] 中国性病艾滋病防治协会HIV合并结核病专业委员会.人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识[J].新发传染病电子杂志,2022,7(1):73-86. [22] ZENNER D,BEER N,HARRIS R J,et al.Treatment of latent tuberculosis infection:an updated network meta analysis[J].Ann Intern Med,2017,167(4):248-255. [23] 杨宇兰,万彬,赵霞,等.中国结核分枝杆菌潜伏感染预防性治疗接受度及影响因素Meta分析[J].结核与肺部疾病杂志,2026,7(1):21-29.
